Simultaneous but not sequential treatment with sodium butyrate improves the antiproliferative effect of α- or β-interferon on a breast cancer cell line

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4109-4114

  Biffi, Anna ^a   Coradini, Danila ^a   Pellizzaro, Cinzia ^a   Pirronello, Ester ^a   Fronzo, Giovanni Di ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

interferon; interferon; Cell growth; Sodium butyrate

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BUTYRIC ACID; CYTOKINE; INTERFERON RECEPTOR; RECOMBINANT ALPHA2A INTERFERON; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

BREAST NEOPLASMS; BUTYRATES; CELL DIVISION; FEMALE; HUMANS; INTERFERON ALFA-2A; INTERFERON-BETA; KINETICS; RECEPTORS, INTERFERON; TUMOR CELLS, CULTURED;

EID: 0032409291     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Landolfo S, Gribaudo G, Angeretti A and Garglio M: Mechanisms of viral inhibition by interferons. Pharm Ther 65: 415-442, 1995.
2. Borden EC and Ball LA: Interferons: biochemical, cell growth inhibitory and immunological effects. Prog Hematol 8: 299-339, 1981.
3. Einhorn S and Strender H: Interferon treatment of human malignancies: a short review. Med Oncol Tumor Pharmacother 10: 25-29, 1993.
4. Branca AA and Baglioni C: Evidence that type I and II interferons have different receptors. Nature 294: 768-770, 1981.
5. 125I-human interferon gamma to high affinity receptors on human fibroblasts. J Biol Chem 257: 11301-11304, 1981.
6. Friedman RM, Manly SP, McMahon M, Kerr, IM and Stark GR: Tanscriptional and post-transcriptional regulation of interferon-induced gene expression in human cells. Cells 38: 745-755, 1984.
7. Levy DE, Kessler DS, Pine R and Darnell JE: Cytoplasmic activation of ISGF3, the positive regulator of interferon α-stimulated transcription, reconstituted in vitro. Gen Dev 3: 1362-1371, 1989.
8. Revel M and Chebath J: Interferon-activated genes. Trends Biol Sci 11: 166-170, 1986.
9. Coradini D, Biffi A, Pirronello E and Di Fronzo G: The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines. Anticancer Res 14: 1779-1784, 1994.
10. Quesada JR, Gutterman JU and Hersh EM: Clinical and immunological study of beta-interferon by intramuscular route in patients with metastatic breast cancer. J Interferon Res 2: 593-599, 1982.
11. Bourgeade MF, Cerutti I and Chany C: Enhancement of interferon antitumor action by sodium buryrate. Cancer Res 39: 4720-4723, 1979.
12. Chany C and Cerutti I: Antitumor therapy based on the use of an immune modulator, arginine butyrate and interferon. Med Oncol Tumor Pharmacother 1: 101-107, 1984.
13. Leder A and Leder P: Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells. Cell 5: 319-322, 1975.
14. Langdon SP, Hawkes MM, Hay FG, Lawrie SS, Schol DJ, Hilgers J, Leonard RCF and Smyth JF: Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res 48: 6161-6165, 1988.